Making early cancer diagnosis possible

Chip Diagnostics is an emerging leader in exosome-based diagnostics, enabling minimally invasive disease detection and monitoring. We unlock the potential of liquid biopsy by fingerprinting diseases with organ-specific signatures, providing actionable clinical data.


We envision Chip Diagnostics at the forefront of advancements in early cancer detection, therapy selection, and patient monitoring.


Our technology is designed to precisely find and interpret disease-specific exosomes in the blood, with the goal of being able to accurately assess disease.


We are exploring multiple disease areas, and 8 peer-reviewed publications provide proof-of-concept validation in over 350 human clinical samples.


Our team includes top academic, clinical, and industry professionals with experience in developing next generation diagnostics.